Variant report
Variant | nsv962268 |
---|---|
Chromosome Location | chr17:16559570-16566202 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr17:16559873-16560077 | HepG2 | liver: | n/a | chr17:16560005-16560016 |
2 | CTCF | chr17:16561460-16561610 | HEK293 | kidney: | n/a | n/a |
3 | CTCF | chr17:16563633-16563719 | Lung_OC | lung: | n/a | n/a |
4 | CTCF | chr17:16561320-16561470 | GM12872 | blood: | n/a | n/a |
5 | CTCF | chr17:16564373-16564423 | GM20000 | blood: | n/a | n/a |
6 | STAT3 | chr17:16565461-16565596 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:16559599-16559649 | H1-hESC | embryonic stem cell: | embryo |
2 | chr17:16559599-16559649 | HCF | heart: | n/a |
3 | chr17:16559599-16559649 | HCT-116 | colon: | n/a |
4 | chr17:16559599-16559649 | HRE | kidney: | n/a |
5 | chr17:16559599-16559649 | Caco-2 | colon: | n/a |
6 | chr17:16559599-16559649 | LNCaP | prostate: | n/a |
7 | chr17:16559599-16559649 | IMR90 | lung: | fetal |
8 | chr17:16559599-16559649 | U87 | brain: | n/a |
9 | chr17:16559599-16559649 | NB4 | blood: | n/a |
10 | chr17:16559599-16559649 | PrEC | prostate: | n/a |
11 | chr17:16559599-16559649 | HL-60 | blood: | n/a |
12 | chr17:16559599-16559649 | HMEC | breast: | n/a |
13 | chr17:16559599-16559649 | ovcar-3 | ovarian: | n/a |
14 | chr17:16559599-16559649 | MCF10A-Er-Src | breast: | n/a |
15 | chr17:16559599-16559649 | HCPEpiC | choroid plexus: | n/a |
16 | chr17:16559599-16559649 | HIPEpiC | eye: | n/a |
17 | chr17:16559599-16559649 | AG09319 | gingival: | n/a |
18 | chr17:16559599-16559649 | HAEpiC | amniotic membrane: | n/a |
19 | chr17:16559599-16559649 | SKMC | muscle: | n/a |
20 | chr17:16559599-16559649 | Hela-S3 | cervix: | n/a |
21 | chr17:16559599-16559649 | CMK | blood: | n/a |
22 | chr17:16559599-16559649 | GM19239 | blood: | n/a |
23 | chr17:16559599-16559649 | AG04449 | skin: | fetal |
24 | chr17:16559599-16559649 | A549 | lung: | n/a |
25 | chr17:16559599-16559649 | AG04450 | lung: | fetal |
26 | chr17:16559599-16559649 | HEK293 | kidney: | embryo |
27 | chr17:16559599-16559649 | HCM | heart: | n/a |
28 | chr17:16559599-16559649 | GM12891 | blood: | n/a |
29 | chr17:16559599-16559649 | Jurkat | blood: | n/a |
30 | chr17:16559599-16559649 | NT2-D1 | testis: | n/a |
31 | chr17:16559599-16559649 | HRCEpiC | kidney: | n/a |
32 | chr17:16559599-16559649 | SK-N-MC | brain: | n/a |
33 | chr17:16559599-16559649 | NH-A | brain: | n/a |
34 | chr17:16559599-16559649 | PFSK-1 | brain: | n/a |
35 | chr17:16559599-16559649 | Hepatocyte | liver: | n/a |
36 | chr17:16559599-16559649 | AG10803 | skin: | n/a |
37 | chr17:16559599-16559649 | NHDF-neo | bronchial: | n/a |
38 | chr17:16559599-16559649 | ECC-1 | luminal epithelium: | n/a |
39 | chr17:16559599-16559649 | BJ | skin: | n/a |
40 | chr17:16559599-16559649 | K562 | blood: | n/a |
41 | chr17:16559599-16559649 | HNPCEpiC | eye: | n/a |
42 | chr17:16559599-16559649 | AG09309 | skin: | n/a |
43 | chr17:16559599-16559649 | SK-N-SH | brain: | n/a |
44 | chr17:16559599-16559649 | GM12892 | blood: | n/a |
45 | chr17:16559599-16559649 | T-47D | breast: | n/a |
46 | chr17:16559599-16559649 | NHBE | bronchial: | n/a |
47 | chr17:16559599-16559649 | HRPEpiC | eye: | n/a |
48 | chr17:16559599-16559649 | SK-N-SH_RA | brain: | n/a |
49 | chr17:16559599-16559649 | GM12878 | blood: | n/a |
50 | chr17:16559599-16559649 | BE2_C | brain: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF624 | TF binding region |
ZNF624 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142753041 | chr17:16559571-16559572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541529973 | chr17:16559599-16559600 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs530333467 | chr17:16559600-16559601 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs528090445 | chr17:16559604-16559605 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550361580 | chr17:16559623-16559624 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs561738500 | chr17:16559636-16559637 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs538935862 | chr17:16559664-16559665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147370982 | chr17:16559669-16559670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116169311 | chr17:16559708-16559709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184599420 | chr17:16559812-16559813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs36116613 | chr17:16559891-16559892 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs534634243 | chr17:16559911-16559912 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs554332980 | chr17:16559915-16559916 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs574483504 | chr17:16559970-16559971 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs543204795 | chr17:16560023-16560024 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs557117193 | chr17:16560027-16560028 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs59486407 | chr17:16560038-16560039 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs187067414 | chr17:16560041-16560042 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs548870874 | chr17:16560073-16560074 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs58164310 | chr17:16560091-16560092 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs541433752 | chr17:16560111-16560112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59594997 | chr17:16560113-16560114 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs530217980 | chr17:16560116-16560117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549953192 | chr17:16560117-16560118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550044690 | chr17:16560127-16560128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569895908 | chr17:16560141-16560142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532593626 | chr17:16560154-16560155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552425009 | chr17:16560155-16560156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35363296 | chr17:16560160-16560161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534280614 | chr17:16560208-16560209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548169759 | chr17:16560222-16560223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529404946 | chr17:16560266-16560267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537142151 | chr17:16560277-16560278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557128244 | chr17:16560309-16560310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577091468 | chr17:16560310-16560311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191703472 | chr17:16560318-16560319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553271480 | chr17:16560342-16560343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142502373 | chr17:16560362-16560363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184295526 | chr17:16560395-16560396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573105651 | chr17:16560414-16560415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59840112 | chr17:16560425-16560426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375742576 | chr17:16560437-16560438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561322912 | chr17:16560477-16560478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574771358 | chr17:16560519-16560520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569193901 | chr17:16560537-16560538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150595635 | chr17:16560577-16560578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566144031 | chr17:16560584-16560585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139618739 | chr17:16560602-16560603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532533411 | chr17:16560673-16560674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570366545 | chr17:16560684-16560685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastric cancer | 18160780 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21509527 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:16557200-16561800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr17:16557400-16570000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr17:16557800-16566000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr17:16561800-16562000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr17:16562000-16566600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr17:16562200-16563400 | Weak transcription | NHEK | skin |
7 | chr17:16563000-16567000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr17:16563400-16564400 | Enhancers | NHEK | skin |
9 | chr17:16564400-16565800 | Weak transcription | NHEK | skin |
10 | chr17:16565800-16566800 | Enhancers | NHEK | skin |
11 | chr17:16566000-16567000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr17:16566200-16567000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr17:16566200-16567000 | Enhancers | HMEC | breast |